Table 2 of
Alapure, Mol Vis 2012; 18:64-73.
Table 2. detailed steroid-induced PSC patients demographics.
| Disease for which steroids were prescribed |
Number of patients |
Steroids used |
Use of Cyclosporin |
Oral or topical therapy |
Time period for which the steroid therapy lasted |
Prescribed dosage of steroid |
Time since PSC developed |
|---|---|---|---|---|---|---|---|
| Renal transplantation | 21 | WY/CY | 5 mg/day | Oral | >2–4 years | 5–10 mg/day | Not recorded |
| Asthma | 08 | WY/DE/DP | - | Oral | >2–4 years | 10 mg/day | Not recorded |
| Lung disease | 02 | WY/DE | - | Oral | >2 years | 7–10 mg/day | Not recorded |
| Arthritis | 03 | OP/DP | - | Oral | >2–3 years | 10 mg/day | Not recorded |
| Allergy | 16 | WY/DE/DP/OP | - | Oral/topical | >2–3 years | 10 mg/day | Not recorded |